Idogen – Introduction to the share

Idogen – Introduction to the share

Idogen - Introduction to the share 29 JuniJun 2021 12:00 - 12:30Online Event

Tuesday June 29th you can meet and ask questions directly to Idogen CEO Anders Karlsson when he gives an introduction to the Idogen share.

Idogen was founded in 2009 and is a Swedish biotech company locacted in Lund, Sweden. Idogen is listed on the First North Growth Market and with a market cap 62 mio. SEK. Idogen develops tolerogenic cell therapies to prevent the patient’s immune system from attacking biological agents, transplanted organs or the body’s own cells or tissues.

 

Information

Idogen - Introduction to the share 29 JuniJun 2021 12:00 - 12:30
Idogen - Introduction to the share Online Event
Introduktion til aktien